Urologix cuts jobs, loses CEO (chief executive officer), but signs deal with Boston
This article was originally published in Clinica
Urologix has reduced its 130-strong workforce by 20% in an attempt to cut costs. The news comes in the wake of the company's first-quarter sales, which at $1.6 million, were below analysts' expectations. Urologix says its Targis system, which uses a proprietary microwave technology to treat benign prostatic hyperplasia, has been well accepted by academic and clinical centres, but that "the sales process in the US is complex".
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.